BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND BCL2, Bcl-2, 596, ENSG00000171791
2531 results:

  • 1. Colonic lymphomatous polyposis mantle cell lymphoma: a case report and review of literature.
    Djiwa T; Koui BBS; Aman NA; Coulibaly ZI; Kouyate M; Kouame KE
    J Med Case Rep; 2024 May; 18(1):219. PubMed ID: 38698463
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Apoptotic effect of 5-fluorouracil-doxorubicin combination on colorectal cancer cell monolayers and spheroids.
    Bilgin S
    Mol Biol Rep; 2024 May; 51(1):603. PubMed ID: 38698270
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparative evaluation of hesperetin-loaded graphene oxide nanosheets (Hsp-GO) as a drug delivery system for colon cancer: synthesis and anticancer efficiency assessment.
    Hadi AS; Haghi M; Barzegar A; Ali M; Feizi H
    Mol Biol Rep; 2024 Apr; 51(1):591. PubMed ID: 38683228
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. LncRNA ANRIL Promotes Glucose Metabolism and Proliferation of Colon cancer in a High-Glucose Environment and is Associated with Worse Outcome in Diabetic Colon cancer Patients.
    Mosaad H; Shalaby SM; Mahmoud NM; Ahmed MM; Fayed A; Ashour HR; Sarhan W
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1371-1381. PubMed ID: 38679999
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeting colorectal cancer: Unravelling the Transcriptomic Impact of Cisplatin and High-THC Cannabis Extract.
    Cherkasova V; Ilnytskyy Y; Kovalchuk O; Kovalchuk I
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674023
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A narrative review on therapeutic potential of naringenin in colorectal cancer: Focusing on molecular and biochemical processes.
    Zamanian MY; Golmohammadi M; Abdullaev B; García MO; Alazbjee AAA; Kumar A; Mohaamed SS; Hussien BM; Khalaj F; Hodaei SM; Shirsalimi N; Moriasi G
    Cell Biochem Funct; 2024 Apr; 42(3):e4011. PubMed ID: 38583080
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. An integrated framework for prognosis prediction and drug response modeling in colorectal liver metastasis drug discovery.
    Zhou X; Qian Y; Ling C; He Z; Shi P; Gao Y; Sui X
    J Transl Med; 2024 Mar; 22(1):321. PubMed ID: 38555418
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Anti-cancer Mechanisms of Diarylpentanoid MS17 (1,5-Bis(2-hydroxyphenyl)-1,4-pentadiene-3-one) in Human Colon cancer Cells: A Proteomics Approach.
    Hon KW; Zainal Abidin SA; Abas F; Othman I; Naidu R
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542474
    [TBL] [Abstract] [Full Text] [Related]  

  • 9.
    Wang N; Zhang L; Leng XX; Xie YL; Kang ZR; Zhao LC; Song LH; Zhou CB; Fang JY
    Gut Microbes; 2024; 16(1):2333790. PubMed ID: 38533566
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Elevated postoperative carcinoembryonic antigen guides adjuvant chemotherapy for stage II colon cancer: a multicentre cohort retrospective study.
    Pu H; Yang W; Liu M; Pang X; Chen Y; Xiong Q
    Sci Rep; 2024 Mar; 14(1):6889. PubMed ID: 38519578
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeted inhibition of colorectal cancer proliferation: The dual-modulatory role of 2,4-DTBP on anti-apoptotic bcl-2 and Survivin proteins.
    Saha P; Hegde M; Chakraborty K; Singha A; Mukerjee N; Ghosh D; Kunnumakkara AB; Khan MS; Ahmad MI; Ghosh A; Kumer A; Sil SK
    J Cell Mol Med; 2024 Apr; 28(7):e18150. PubMed ID: 38494866
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mTOR signaling pathway].
    Tao SN; Liu XC; Wang YY; Yang H
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
    [No Abstract]    [Full Text] [Related]  

  • 13. α‑Phellandrene enhances the apoptosis of HT‑29 cells induced by 5‑fluorouracil by modulating the mitochondria‑dependent pathway.
    Susanto AC; Hartajanie L; Wu CC
    Oncol Rep; 2024 Apr; 51(4):. PubMed ID: 38456489
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids.
    Gagliano T; Kerschbamer E; Baccarani U; Minisini M; Di Giorgio E; Dalla E; Weichenberger CX; Cherchi V; Terrosu G; Brancolini C
    Biomed Pharmacother; 2024 Apr; 173():116374. PubMed ID: 38447451
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Synthesis and mitochondria-localized iridium (III) complexes induce cell death through pyroptosis and ferroptosis pathways.
    Hu H; Zhang F; Sheng Z; Tian S; Li G; Tang S; Niu Y; Yang J; Liu Y
    Eur J Med Chem; 2024 Mar; 268():116295. PubMed ID: 38437750
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. BCL-X
    Jenkins LJ; Luk IY; Chionh F; Tan T; Needham K; Ayton J; Reehorst CM; Vukelic N; Sieber OM; Mouradov D; Gibbs P; Williams DS; Tebbutt NC; Desai J; Hollande F; Dhillon AS; Lee EF; Merino D; Fairlie WD; Mariadason JM
    Cell Death Dis; 2024 Mar; 15(3):183. PubMed ID: 38429301
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The potential therapeutic effect of melatonin in oxaliplatin combination therapy against chemoresistant colorectal cancer cells.
    Dehghanzad M; Mohammadi M; Nejati M; Pouremamali F; Maroufi NF; Akbarzadeh M; Samadi N; Nouri M
    Mol Biol Rep; 2024 Feb; 51(1):348. PubMed ID: 38401018
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Kurarinone targets JAK2-STAT3 signaling in colon cancer-stem-like cells.
    Prajapati KS; Kumar S
    Cell Biochem Funct; 2024 Mar; 42(2):e3959. PubMed ID: 38390770
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The combined anti-tumor effects of 5-fluorouracil and neurokinin receptor inhibitor, aprepitant, against colorectal cancer: In vitro and in vivo study.
    Alalikhan A; Ebrahimi S; Aliee A; Mirzavi F; Hashemy SI
    Med Oncol; 2024 Feb; 41(3):70. PubMed ID: 38340190
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Building an Efficient Peritoneal Surface Malignancies Program Despite the Lower-Middle-Income Barriers: Ukraine Experience.
    Kopetskyi V; Antoniv M; Yarema R; Maksymovskyi V; Chetverikova-Ovchinnik V; Kryzhevskyi V; Volodko N; Gushchin V; Nikiforchin A
    JCO Glob Oncol; 2024 Feb; 10():e2300432. PubMed ID: 38330272
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 127.